# Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

> **NCT02733588** · PHASE2 · COMPLETED · sponsor: **Xeris Pharmaceuticals** · enrollment: 8 (actual)

## Conditions studied

- Hypoglycemia
- Complications of Bariatric Procedures

## Interventions

- **DRUG:** G-Pump™ (glucagon infusion)

## Key facts

- **NCT ID:** NCT02733588
- **Lead sponsor:** Xeris Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-04-05
- **Final completion:** 2017-06-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733588, "Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02733588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*